![]() |
市場調查報告書
商品編碼
1541542
透明質酸原料市場報告按應用(眼科、骨科、皮膚科、藥物傳輸、醫療器械塗層、手術粘連預防、生物材料和植入物、細胞和組織保存)和地區2024-2032Hyaluronic Acid Raw Material Market Report by Application (Ophthalmology, Orthopedics, Dermatology, Drug Delivery, Medical Device Coating, Surgical Adhesion Prevention, Biomaterials and Implants, Cell and Tissue Preservation), and Region 2024-2032 |
IMARC Group年全球透明質酸原料市場規模達71億美元。
透明質酸原料是用來製造天然化合物的物質。這種酸天然存在於眼睛、頭髮、關節、神經、軟骨和皮膚細胞外基質中。也可由小麥蛋白腖、糖和某些細菌發酵合成。這些成分有助於支持結締組織的功能,並透過增加蛋白質和調節皮膚中的水分濃度來促進膠原蛋白結合。局部應用酸可以幫助皮膚再生並減少發炎。因此,它在化妝品、藥物傳輸系統、藥品和營養補充劑的製造中廣泛使用。
全球製藥業的顯著成長是創造積極市場前景的關鍵因素。透明質酸作為黏彈性和抗手術黏附劑,廣泛用於眼科、皮膚科和骨科手術,作為組織黏附的機械屏障。此外,大眾對抗皺和抗衰老面霜以及美容增強解決方案的需求不斷成長,也推動了市場成長。此外,各種技術進步,例如標靶藥物傳遞和再生醫學創新解決方案的開發,也是其他生長誘導因素。醫療保健提供者廣泛使用透明質酸注射來提供潤滑、減少發炎並促進關節中的軟骨和骨骼生長。其他因素,包括消費者支出能力的提高以及廣泛的研發(R&D)活動,預計將推動市場成長。
The global hyaluronic acid raw material market size reached US$ 7.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.8 Billion by 2032, exhibiting a growth rate (CAGR) of 5.7% during 2024-2032.
Hyaluronic acid raw materials are the substances used for the manufacturing of the natural compound. The acid is naturally present in the eyes, hair, joints, nerves, cartilages and extracellular matrix in the skin. It can also be synthesized by fermenting wheat peptones, sugar and certain bacteria. These ingredients aid in supporting the functioning of the connective tissues and promoting collagen binding by building up the proteins and regulating water concentration in the skin. The topical application of the acid can assist in the regeneration of the skin and reduce inflammation. As a result, it finds extensive applications in the manufacturing of cosmetics, drug delivery systems, pharmaceuticals and nutritional supplements.
Significant growth in the pharmaceutical industry across the globe is of the key factors creating a positive outlook for the market. Hyaluronic acid acts as a viscoelastic and anti-surgical adhesion agent, which is widely used in ophthalmic, dermatological and orthopedic procedures as a mechanical barrier for tissue adherence. Moreover, the increasing demand for anti-wrinkle and anti-aging creams and solutions among the masses for cosmetic enhancements is providing a thrust to the market growth. Additionally, various technological advancements, such as the development of innovative solutions for targeted drug delivery and regenerative medicines, are acting as other growth-inducing factors. Healthcare providers are extensively using hyaluronic acid injections to provide lubrication, reduce inflammation and promote cartilage and bone growth in the joint. Other factors, including rising expenditure capacities of the consumers, along with extensive research and development (R&D) activities, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global hyaluronic acid raw material market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on application.
Ophthalmology
Cataract Surgery
Aqueous Eye Drop
Contact Lens
Orthopedics
Viscosupplements
Bone Regeneration
Dermatology
Intradermal
Dermal Filler
Wound Healing
Drug Delivery
Medical Device Coating
Surgical Adhesion Prevention
Biomaterials and Implants
Cell and Tissue Preservation
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Anika Therapeutics Inc., Contipro a.s., Galderma S.A., LG Chem Ltd., Lifecore Biomedical LLC (Landec Corporation), Sanofi S.A., Seikagaku Corporation, Smith & Nephew plc and Zimmer Biomet.